The Thoracic Drainage Devices Market in Germany anticipates that the ongoing surge in respiratory complications linked to COVID-19 will present new growth prospects for the thoracic drainage devices sector during the forecast period. On the other hand, it has been observed that thoracic drainage systems play a vital role in reducing the widespread transmission of COVID-19. Individuals affected by COVID-19 face an elevated risk of developing acute respiratory distress syndrome (ARDS), necessitating the use of invasive mechanical ventilation.
Global thoracic drainage device market size reached approximately $688 million in 2022, and the market is anticipated to demonstrate a compound annual growth rate (CAGR) of 4.6%. By the conclusion of 2032, it is expected to surpass the $1.07 billion mark in valuation.
Download a Sample Copy of This Report:
The global healthcare landscape is constantly evolving to address the growing healthcare needs of an aging population and the increasing incidence of respiratory conditions. In this changing environment, thoracic drainage devices have emerged as a crucial tool in the treatment and management of respiratory conditions. These devices, designed to remove air or fluid from the pleural space, play a pivotal role in patient care, and their market is experiencing steady growth as the demand for such devices rises in tandem with respiratory conditions worldwide.
Respiratory conditions, including pneumonia, pneumothorax, pleural effusion, and empyema, can be life-threatening if not managed effectively. Patients suffering from these conditions often require thoracic drainage procedures to relieve symptoms, promote lung healing, and prevent further complications. Thoracic drainage devices, such as chest tubes and pleural catheters, are essential tools used by healthcare professionals to drain air, blood, or fluid from the pleural space, allowing the lung to re-expand and the patient to breathe more comfortably.
One significant factor driving the growth of the global thoracic drainage devices market is the aging population. As people age, they become more susceptible to respiratory conditions, and the elderly are often at greater risk for conditions like pneumonia and chronic obstructive pulmonary disease (COPD). Additionally, with the rise of non-communicable diseases such as diabetes and heart disease, the incidence of respiratory complications in older individuals has also increased.
The COVID-19 pandemic further highlighted the importance of thoracic drainage devices in the management of severe respiratory conditions. As the pandemic swept across the globe, healthcare providers faced an unprecedented surge in patients with acute respiratory distress syndrome (ARDS) and severe pneumonia. Thoracic drainage devices were instrumental in relieving respiratory distress in many of these cases, underscoring their crucial role in managing respiratory emergencies.
In the thoracic drainage device market, prominent players include Merit Medical Systems, Medela LLC, Smiths Medical, ATMOS MedizinTechnik GmbH & Co. KG., Becton, Cook Group, Inc., Maquet Holding B.V. & Co. KG, and Medela, Inc.
Companies operating in the thoracic drainage devices market are diligently focusing on tailoring drainage devices to meet the specific needs of end-users. Key producers are employing growth strategies such as advancing thoracic drainage systems, forging collaborations, forming partnerships, and engaging in acquisitions.
Medela LLC, a renowned manufacturer of nursing supplies and medical vacuum technology, announced in December 2020 that its “Thopaz+ Digital Chest Drainage and Monitoring System” boasts an effective filtration mechanism designed to prevent the passage of aerosolized virus particles, including SARS-CoV-2. In April 2022, Merit Medical Systems, Inc. introduced the ReSolve Thoracostomy Tray. This comprehensive tray includes all the necessary supplies for performing a thoracostomy, a minimally invasive surgical procedure that obviates the need for opening the patient’s chest to drain fluids or air.
Purchases, Agreements, and Collaborations
In January 2022, ICU Medical acquired Smiths Medical from Smiths Group. This strategic move bolstered ICU Medical’s global presence and established it as one of the leading infusion treatment companies, incorporating Smiths Medical’s vascular access and critical care products, as well as its medical infusion devices and syringes, into its portfolio.
Segments of Thoracic Drainage Devices Industry Research
- By Product :
- Pleural Drainage Catheters
- Secured Needles
- Thoracic Drainage Kits
- Thoracic Drainage Systems
- By Application :
- Thoracic Surgeries & Pulmonology
- Cardiac Surgeries
- General Intensive Care & Emergency Medicine
- Infectious Diseases
- By End User :
- Ambulatory Surgical Centers
- Specialty Clinics
- By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
Get Customization on this Report:
The global thoracic drainage devices market is experiencing steady growth, driven by multiple factors, including the aging population, the increasing prevalence of respiratory conditions, the impact of the COVID-19 pandemic, and technological advancements. These devices have become indispensable in the management of respiratory emergencies and are contributing to improved patient outcomes. As healthcare systems worldwide continue to evolve, it is likely that the thoracic drainage devices market will remain on its growth trajectory, ensuring that patients with respiratory conditions receive the best possible care.
US Sales Office
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583, +353-1-4434-232